Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
2019 · Vaccine · 61 citations
https://doi.org/10.1016/j.vaccine.2019.03.043
M
Mohamed El Idrissi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
1.7K
Citations
14
h-index
14
i10-index
Mohamed El Idrissi is an academic researcher. The author has contributed to research in topics: Herpesvirus Infections and Treatments & Acne and Rosacea Treatments and Effects & Orthopedic Surgery and Rehabilitation. The author has an h-index of 14, co-authored 43 publications.
ORCID: 0000-0002-3306-3062Papers by this author
worksAntibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
2021 · npj Vaccines · 58 citations
https://doi.org/10.1038/s41541-021-00337-0
Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older
2014 · BMC Infectious Diseases · 41 citations
https://doi.org/10.1186/1471-2334-14-425
Safety and Immunogenicity of an Adjuvanted <i>Clostridioides difficile</i> Vaccine Candidate in Healthy Adults: A Randomized Placebo-Controlled Phase 1 Study
2024 · The Journal of Infectious Diseases · 4 citations
https://doi.org/10.1093/infdis/jiae466
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat